Robert E. Mcnamara's most recent trade in AVITA Medical Inc was a trade of 10,022 Common Stock done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AVITA Medical Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 10,022 | 66,771 | - | - | Common Stock | |
| AVITA Medical Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 4,295 | 4,295 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Robert E. Mcnamara | Director | Purchase of securities on an exchange or from another person at price $ 8.30 per share. | 06 Mar 2025 | 11,000 | 56,749 | - | 8.3 | 91,300 | Common Stock |
| AVITA Medical Inc | Robert E. Mcnamara | Director | Purchase of securities on an exchange or from another person at price $ 10.09 per share. | 20 Feb 2025 | 10,000 | 45,749 | - | 10.1 | 100,900 | Common Stock |
| Axonics Inc | Robert E. Mcnamara | Director | Sale or transfer of securities back to the company at price $ 71.00 per share. | 15 Nov 2024 | 14,861 | 0 (0%) | 0% | 71 | 1,055,131 | Common Stock |
| Axonics Inc | Robert E. Mcnamara | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Robert E. Mcnamara | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2024 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Robert E. Mcnamara | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2024 | 3,333 | 0 | - | - | Stock Option (Right to Buy) | |
| AVITA Medical Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 9.00 per share. | 19 Aug 2024 | 10,000 | 35,749 | - | 9 | 90,000 | Common Stock |
| AVITA Medical Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 9,200 | 25,749 | - | - | Common Stock | |
| AVITA Medical Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 3,943 | 3,943 | - | - | Stock Options (Right to Buy) | |
| Axonics Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 3,000 | 14,861 (0%) | 0% | 0 | Common Stock | |
| AVITA Medical Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 10,374 | 10,374 | - | - | Common Stock | |
| AVITA Medical Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 6,175 | 16,549 | - | - | Common Stock | |
| AVITA Medical Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 4,446 | 4,446 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 2,646 | 2,646 | - | - | Stock Options (Right to Buy) | |
| Alpha Teknova Inc | Robert Mcnamara E. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Jun 2023 | 31,959 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Alpha Teknova Inc | Mcnamara E. Robert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 18,815 | 28,172 | - | 0 | Common Stock | |
| Alpha Teknova Inc | Robert E. Mcnamara | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Jun 2023 | 18,815 | 9,357 | - | 0 | Common Stock | |
| Alpha Teknova Inc | E. Mcnamara Robert | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Jun 2023 | 12,292 | 31,959 | - | - | Non-Qualified Stock Option (right to buy) | |
| Axonics Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 2,100 | 11,861 (0%) | 0% | 0 | Common Stock | |
| Alpha Teknova Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 9,357 | 9,357 | - | 0 | Common Stock | |
| Axonics Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 2,261 | 9,761 (0%) | 0% | 0 | Common Stock | |
| Alpha Teknova Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 44,251 | 44,251 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Robert E. Mcnamara | Director | Sale of securities on an exchange or to another person at price $ 51.83 per share. | 13 Jan 2021 | 9,167 | 7,500 (0%) | 0% | 51.8 | 475,133 | Common Stock |
| Axonics Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2020 | 3,500 | 16,667 (0%) | 0% | 0 | Common Stock |